No Detail Found!

Comparison of eficacy of daily and alternate day maintenance treatment of GERD with Vonoprazan 10-mg using Gastroesophageal Reflux Disease Symptom Assessment Scale

Author(s)
Tazeen Rasheed OMI Hospital, Karachi, Pakistan. Address: C-404, Al-Habib Pride, CL-8/5, Civil Lines, Karachi - Pakistan.
Bader Faiyaz Zuberi OMI Hospital, Karachi, Pakistan. Address: C-404, Al-Habib Pride, CL-8/5, Civil Lines, Karachi - Pakistan.
Faiza Sadaqat Ali OMI Hospital, Karachi, Pakistan. Address: C-404, Al-Habib Pride, CL-8/5, Civil Lines, Karachi - Pakistan.
Sana Muhammad Hussain OMI Hospital, Karachi, Pakistan. Address: C-404, Al-Habib Pride, CL-8/5, Civil Lines, Karachi - Pakistan.
Pawan Kumar OMI Hospital, Karachi, Pakistan. Address: C-404, Al-Habib Pride, CL-8/5, Civil Lines, Karachi - Pakistan.
Anoshia Saleem OMI Hospital, Karachi, Pakistan. Address: C-404, Al-Habib Pride, CL-8/5, Civil Lines, Karachi - Pakistan.
Abstract
Objectives: To compare eficacy of 10-mg of vonoprazan daily & on alternate days by Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS) Method: This prospective interventional cohort was done at Department of Medicine/Gastroenterology Dow Medical College, Karachi, Pakistan during the period August 2022 & January 2023. Potential participants fulfilling inclusion and exclusion criteria were asked to fill out GSAS questionnaires after their written consent. Patients were allocated in to two groups using random tables. Group-A was given Tab Vonoprazan 10-mg daily for two weeks. Group-B was given Tab Vonoprazan 10-mg on alternate day. GSAS was scored by totaling scores across symptoms and then they are divided by the total number of non-missing symptom scores. Both groups were assessed week-0 & week-2. Results: Only 90 proformas that were completely filled were included, Group-A had 30 males and 15 females while Group-B had 29 males and 16 females. No significant diference in score was found in GSAS score at week-0 except that in item 'gurgling' while at week two there was no significant diference between any of the items. Total GSAS score were significantly lower at Week-2 than at week-0 ( p = <.001). Conclusions: Vonoprazan of 10-mg on alternate day is equally efective as 10-mg daily in maintenance of GERD patients at two weeks.
Publication Details
Page(s) 623-628
Published Journal: Pakistan Journal of Medical Sciences, Volume: 40, Issue: 4, Year: 2024

Request the full text from PASTIC

Keywords
Vonoprazan, GERD, Gastroesophageal Reflux Disease Symptom Assessment Scale (GSAS)
0

Citations

0

Downloads

89

Views